ArticleBMC infectious diseases2024

Longevity of hybrid immunity against SARS-CoV-2 in adults vaccinated with an adenovirus-based COVID-19 vaccine.

Memory Mvula et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.